It could reasonably be hypothesized, even if complementally analyses should be performed, that this genes set might be useful to discriminate GBM patients whose tumor will respond to an association of a specific FGFR1 inhibitor with radiotherapy. Here, FGFR1 is linked to glioblastoma.